Cash flow IXICO plc

Equities

IXI

GB00BFXR4C20

Biotechnology & Medical Research

Market Closed - London S.E. Other stock markets 11:35:26 2025-12-05 EST			5-day change	1st Jan Change
10.75 ^GBX	0.00%		-2.27%	-8.51%

12-01	IXICO plc Announces Scientific Advisory Board Appointments, Effective December 1, 2025	CI
11-17	Ixico wins GBP3.7 million deal to support Huntington's Disease trial	AN

5a9c2f0b6123d609ba64153.ltPSgX_v_lIVKoxm8zN9Iw99wxNLW71lHGZySjBfvrA.0Jq0shm2txN7ZssBi0cJZ04Xs3ooAvAiKjRHK0U7x53ahuawPt7KE2Jt1Q

Published financial data: IXICO PLC

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: September	2020	2021	2022	2023	2024
Revenues	9.53M	9.19M	8.64M	6.66M	5.77M
Total Revenues	9.53M	9.19M	8.64M	6.66M	5.77M
Cost of Goods Sold, Total	3.19M	3.17M	3.4M	3.4M	3.06M
Gross Profit	6.35M	6.02M	5.24M	3.27M	2.71M
Selling General & Admin Expenses, Total	4.79M	4.05M	3.81M	4.18M	4.31M
R&D Expenses	1.31M	1.24M	1.22M	925K	1.34M
Other Operating Expenses	-606K	-448K	-689K	-393K	-781K
Other Operating Expenses, Total	5.49M	4.84M	4.34M	4.71M	4.86M
Operating Income	856K	1.18M	908K	-1.44M	-2.15M
Interest Expense, Total	-18K	-22K	-33K	-29K	-25K
Interest And Investment Income	20K	1K	10K	105K	85K
Net Interest Expenses	2K	-21K	-23K	76K	60K
EBT, Excl. Unusual Items	858K	1.16M	885K	-1.36M	-2.09M
Restructuring Charges	-	-	-	-	-
Merger & Related Restructuring Charges	-	-	-	-	-
Asset Writedown	-	-	-	-	-
Other Unusual Items	-	-	-	-	-
EBT, Incl. Unusual Items	858K	1.16M	885K	-1.36M	-2.09M
Income Tax Expense	-94K	-415K	-147K	-183K	-93K
Earnings From Continuing Operations	952K	1.58M	1.03M	-1.18M	-2M
Net Income to Company	952K	1.58M	1.03M	-1.18M	-2M
Net Income - (IS)	952K	1.58M	1.03M	-1.18M	-2M
Net Income to Common Incl Extra Items	952K	1.58M	1.03M	-1.18M	-2M
Net Income to Common Excl. Extra Items	952K	1.58M	1.03M	-1.18M	-2M
Per Share Items
Net EPS - Basic	0.02	0.03	0.02	-0.02	-0.04
Basic EPS - Continuing Operations	0.02	0.03	0.02	-0.02	-0.04
Basic Weighted Average Shares Outstanding	47.04M	47.66M	48.15M	48.31M	48.31M
Net EPS - Diluted	0.02	0.03	0.02	-0.02	-0.04
Diluted EPS - Continuing Operations	0.02	0.03	0.02	-0.02	-0.04
Diluted Weighted Average Shares Outstanding	47.55M	50.41M	50.76M	48.31M	48.31M
Normalized Basic EPS	0.01	0.02	0.01	-0.02	-0.03
Normalized Diluted EPS	0.01	0.01	0.01	-0.02	-0.03
Supplemental Items
EBITDA	1.05M	1.55M	1.29M	-1.09M	-1.94M
EBITA	887K	1.22M	945K	-1.39M	-2.08M
EBIT	856K	1.18M	908K	-1.44M	-2.15M
EBITDAR	1.07M	1.55M	1.3M	-1.09M	-1.94M
Effective Tax Rate - (Ratio)	-10.96	-35.78	-16.61	13.45	4.44
Deferred Domestic Taxes	-	-	-	-	-
Total Deferred Taxes	-	-	-	-	-
Normalized Net Income	536K	725K	553K	-851K	-1.31M
Interest on Long-Term Debt	18K	22K	33K	29K	22K
Supplemental Operating Expense Items
Selling and Marketing Expenses	1.58M	1.15M	1.23M	1.32M	1.4M
General and Administrative Expenses	3.19M	2.9M	2.58M	2.85M	2.91M
Research And Development Expense From Footnotes	1.36M	1.34M	1.37M	1.1M	1.5M
Net Rental Expense, Total	21K	2K	1K	1K	1K
Imputed Operating Lease Interest Expense	-	869	474	514	571
Imputed Operating Lease Depreciation	-	1.13K	526	486	429
Stock-Based Comp., Other (Total)	184K	204K	79K	52K	8K
Total Stock-Based Compensation	184K	204K	79K	52K	8K

Fiscal Period: September	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	7.94M	6.68M	5.77M	4.03M	1.79M
Total Cash And Short Term Investments	7.94M	6.68M	5.77M	4.03M	1.79M
Accounts Receivable, Total	1.4M	2.61M	2.25M	945K	1.63M
Other Receivables	396K	509K	487K	599K	529K
Total Receivables	1.79M	3.12M	2.73M	1.54M	2.16M
Prepaid Expenses	550K	552K	652K	684K	518K
Other Current Assets, Total	-	-	96K	27K	24K
Total Current Assets	10.29M	10.36M	9.25M	6.29M	4.49M
Gross Property Plant And Equipment	1.44M	1.92M	2.08M	2.16M	2.23M
Accumulated Depreciation	-430K	-841K	-1.27M	-1.65M	-1.88M
Net Property Plant And Equipment	1.01M	1.08M	817K	518K	350K
Other Intangibles, Total	796K	2.71M	4.59M	6.15M	6.34M
Other Long-Term Assets, Total	-	-	-	39K	9K
Total Assets	12.1M	14.15M	14.66M	12.99M	11.19M
Liabilities
Accounts Payable, Total	176K	734K	254K	86K	83K
Accrued Expenses, Total	1.29M	953K	508K	464K	553K
Current Portion of Leases	168K	78K	122K	112K	164K
Current Income Taxes Payable	171K	42K	56K	58K	180K
Unearned Revenue Current, Total	761K	475K	673K	529K	591K
Other Current Liabilities	105K	13K	122K	32K	3K
Total Current Liabilities	2.68M	2.3M	1.74M	1.28M	1.57M
Long-Term Leases	45K	519K	394K	275K	150K
Deferred Tax Liability Non Current	-	-	-	-	-
Other Non Current Liabilities	257K	114K	33K	2K	-
Total Liabilities	2.98M	2.93M	2.16M	1.56M	1.72M
Common Stock, Total	471K	482K	482K	484K	484K
Additional Paid In Capital	84.5M	84.8M	84.8M	84.8M	84.8M
Retained Earnings	-9.38M	-7.6M	-6.23M	-7.36M	-9.35M
Comprehensive Income and Other	-66.47M	-66.46M	-66.56M	-66.49M	-66.47M
Total Common Equity	9.12M	11.22M	12.49M	11.43M	9.46M
Total Equity	9.12M	11.22M	12.49M	11.43M	9.46M
Total Liabilities And Equity	12.1M	14.15M	14.66M	12.99M	11.19M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	47.09M	48.15M	48.15M	48.35M	48.35M
ECS Total Common Shares Outstanding	47.09M	48.15M	48.15M	48.35M	48.35M
Book Value / Share	0.19	0.23	0.26	0.24	0.2
Tangible Book Value	8.32M	8.51M	7.91M	5.28M	3.13M
Tangible Book Value Per Share	0.18	0.18	0.16	0.11	0.06
Total Debt	213K	597K	516K	387K	314K
Net Debt	-7.73M	-6.09M	-5.25M	-3.64M	-1.47M
Debt Equivalent Oper. Leases	168K	16K	8K	8K	8K
Account Code - Inventory Valuation	3	3	-	3	3
Machinery, Total	836K	960K	1.12M	1.2M	1.22M
Full Time Employees	82	93	90	89	81
Accumulated Allowance for Doubtful Accounts (Supple)	-	-	-	-	-
Order Backlog	21.7M	18.8M	16M	14.8M	15.3M

Fiscal Period: September	2020	2021	2022	2023	2024
Net Income	952K	1.58M	1.03M	-1.18M	-2M
Depreciation & Amortization - CF	356K	464K	451K	400K	241K
Amortization of Goodwill and Intangible Assets - (CF)	31K	40K	37K	47K	71K
Depreciation & Amortization, Total	387K	504K	488K	447K	312K
Amortization of Deferred Charges, Total - (CF)	51K	105K	151K	178K	163K
(Gain) Loss From Sale Of Asset	1K	-	-	-	-
Asset Writedown & Restructuring Costs	2K	-	41K	14K	-
Stock-Based Compensation (CF)	184K	204K	79K	52K	8K
Other Operating Activities, Total	189K	-253K	49K	-174K	-6K
Change In Accounts Receivable	297K	-1.11M	280K	1.29M	-559K
Change In Accounts Payable	-128K	-410K	-696K	-327K	351K
Cash from Operations	1.94M	613K	1.42M	302K	-1.73M
Capital Expenditure	-686K	-170K	-187K	-100K	-34K
Cash Acquisitions	-	-	-	-	-
Sale (Purchase) of Intangible assets	-456K	-1.98M	-2.06M	-1.86M	-437K
Other Investing Activities, Total	20K	1K	6K	99K	94K
Cash from Investing	-1.12M	-2.15M	-2.24M	-1.86M	-377K
Long-Term Debt Repaid, Total	-177K	-44K	-114K	-158K	-134K
Total Debt Repaid	-177K	-44K	-114K	-158K	-134K
Issuance of Common Stock	65K	314K	-	2K	-
Other Financing Activities, Total	-18K	-	-	-	-
Cash from Financing	-130K	270K	-114K	-156K	-134K
Foreign Exchange Rate Adjustments	-2K	9K	14K	-20K	-1K
Net Change in Cash	681K	-1.26M	-915K	-1.74M	-2.24M
Supplemental Items
Cash Interest Paid	18K	-	-	-	-
Cash Income Tax Paid (Refund)	-447K	-354K	-489K	-440K	-552K
Levered Free Cash Flow	217K	-2.24M	-1.13M	-1.42M	-1.56M
Unlevered Free Cash Flow	228K	-2.23M	-1.11M	-1.4M	-1.54M
Change In Net Working Capital	-213K	1.62M	154K	-783K	209K
Net Debt Issued / Repaid	-177K	-44K	-114K	-158K	-134K

Fiscal Period: September	2020	2021	2022	2023	2024
Profitability
Return on Assets	4.69	5.62	3.93	-6.5	-11.14
Return on Total Capital	6.2	6.98	4.52	-7.23	-12.47
Return On Equity %	11.18	15.49	8.61	-9.85	-19.15
Return on Common Equity	11.18	15.49	8.61	-9.85	-19.15
Margin Analysis
Gross Profit Margin %	66.58	65.55	60.66	49.06	47.02
SG&A Margin	50.22	44.08	44.05	62.64	74.73
EBITDA Margin %	11.04	16.82	14.97	-16.38	-33.73
EBITA Margin %	9.31	13.29	10.93	-20.86	-36.13
EBIT Margin %	8.98	12.85	10.51	-21.56	-37.36
Income From Continuing Operations Margin %	9.99	17.14	11.94	-17.67	-34.7
Net Income Margin %	9.99	17.14	11.94	-17.67	-34.7
Net Avail. For Common Margin %	9.99	17.14	11.94	-17.67	-34.7
Normalized Net Income Margin	5.63	7.89	6.4	-12.76	-22.7
Levered Free Cash Flow Margin	2.27	-24.37	-13.12	-21.29	-27.04
Unlevered Free Cash Flow Margin	2.39	-24.22	-12.88	-21.02	-26.76
Asset Turnover
Asset Turnover	0.84	0.7	0.6	0.48	0.48
Fixed Assets Turnover	14.33	8.77	9.11	9.99	13.29
Receivables Turnover (Average Receivables)	5.73	4.59	3.56	4.18	4.47
Short Term Liquidity
Current Ratio	3.85	4.51	5.33	4.91	2.85
Quick Ratio	3.64	4.27	4.9	4.35	2.51
Operating Cash Flow to Current Liabilities	0.72	0.27	0.82	0.24	-1.1
Days Sales Outstanding (Average Receivables)	63.89	79.59	102.62	87.4	81.85
Average Days Payable Outstanding	44.4	52.46	53.03	18.28	10.12
Long Term Solvency
Total Debt/Equity	2.34	5.32	4.13	3.39	3.32
Total Debt / Total Capital	2.28	5.05	3.97	3.27	3.21
LT Debt/Equity	0.49	4.63	3.15	2.41	1.58
Long-Term Debt / Total Capital	0.48	4.39	3.03	2.33	1.53
Total Liabilities / Total Assets	24.61	20.69	14.75	11.99	15.41
EBIT / Interest Expense	47.56	53.68	27.52	-49.55	-86.16
EBITDA / Interest Expense	69.06	76.59	42.3	-34.14	-73.68
(EBITDA - Capex) / Interest Expense	30.94	68.86	36.64	-37.59	-75.04
Total Debt / EBITDA	0.17	0.35	0.37	-0.39	-0.17
Net Debt / EBITDA	-6.22	-3.61	-3.76	3.68	0.8
Total Debt / (EBITDA - Capex)	0.38	0.39	0.43	-0.36	-0.17
Net Debt / (EBITDA - Capex)	-13.88	-4.02	-4.34	3.34	0.79
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	26.07	-3.59	-5.95	-22.89	-13.49
Gross Profit, 1 Yr. Growth %	28.41	-5.07	-12.96	-37.63	-17.09
EBITDA, 1 Yr. Growth %	129.19	46.96	-12.74	-184.39	78.11
EBITA, 1 Yr. Growth %	129.2	37.66	-18.39	-247.09	49.86
EBIT, 1 Yr. Growth %	135.16	37.97	-18.78	-258.26	49.9
Earnings From Cont. Operations, 1 Yr. Growth %	120.37	65.44	-31.75	-214.15	69.86
Net Income, 1 Yr. Growth %	120.37	65.44	-31.75	-214.15	69.86
Normalized Net Income, 1 Yr. Growth %	134.43	35.2	-19.33	-253.79	53.86
Diluted EPS Before Extra, 1 Yr. Growth %	117.4	56.01	-32.33	-220.19	69.76
Accounts Receivable, 1 Yr. Growth %	-27.83	87.31	-14.01	-57.94	72.91
Net Property, Plant and Equip., 1 Yr. Growth %	220.89	6.61	-24.42	-36.6	-32.43
Total Assets, 1 Yr. Growth %	13.04	16.97	2.77	-11.36	-13.87
Tangible Book Value, 1 Yr. Growth %	9.13	2.26	-9.84	-33.15	-40.83
Common Equity, 1 Yr. Growth %	15.15	23.05	8.83	-8.49	-17.21
Cash From Operations, 1 Yr. Growth %	-1.59K	-68.02	132.3	-78.79	-673.51
Capital Expenditures, 1 Yr. Growth %	216.13	-75.22	10	-46.52	-66
Levered Free Cash Flow, 1 Yr. Growth %	-128.69	-1.13K	-55.3	25.14	9.84
Unlevered Free Cash Flow, 1 Yr. Growth %	-130.18	-1.08K	-55.87	25.83	10.14
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	32.93	10.25	-4.78	-14.84	-18.32
Gross Profit, 2 Yr. CAGR %	41.42	10.41	-9.11	-26.32	-28.09
EBITDA, 2 Yr. CAGR %	26.35	83.53	10.91	-14.19	22.6
EBITA, 2 Yr. CAGR %	12.81	77.62	3.22	9.56	48.47
EBIT, 2 Yr. CAGR %	3.64	80.13	2.99	13.37	54.02
Earnings From Cont. Operations, 2 Yr. CAGR %	19.38	90.94	4.12	-11.73	39.25
Net Income, 2 Yr. CAGR %	19.38	90.94	4.12	-11.73	39.25
Normalized Net Income, 2 Yr. CAGR %	4.02	78.03	1.56	11.38	53.82
Diluted EPS Before Extra, 2 Yr. CAGR %	-0	84.16	0.75	-9.82	42.84
Accounts Receivable, 2 Yr. CAGR %	-13.49	16.27	26.92	-39.86	-14.72
Net Property, Plant and Equip., 2 Yr. CAGR %	262.89	84.96	-10.24	-30.78	-34.55
Total Assets, 2 Yr. CAGR %	8.16	14.99	10.07	-4.56	-12.63
Tangible Book Value, 2 Yr. CAGR %	6.82	5.64	-2.54	-22.37	-37.11
Common Equity, 2 Yr. CAGR %	11.57	19.04	17.05	-0.2	-12.96
Cash From Operations, 2 Yr. CAGR %	133.47	117.15	-13.81	-29.81	10.29
Capital Expenditures, 2 Yr. CAGR %	238.13	-11.49	-47.79	-23.3	-57.36
Levered Free Cash Flow, 2 Yr. CAGR %	-32.15	72.18	128.74	-25.21	17.24
Unlevered Free Cash Flow, 2 Yr. CAGR %	-30.42	71.65	120.99	-25.48	17.73
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	32.47	19.44	4.56	-11.24	-14.39
Gross Profit, 3 Yr. CAGR %	39.97	23.82	1.99	-19.83	-23.37
EBITDA, 3 Yr. CAGR %	-5.31	32.87	41.27	1.25	9.46
EBITA, 3 Yr. CAGR %	-11.69	20.55	34.66	16.15	21.62
EBIT, 3 Yr. CAGR %	-15.74	14.01	35.62	18.85	24.43
Earnings From Cont. Operations, 3 Yr. CAGR %	-14.76	33.1	33.68	7.36	9.79
Net Income, 3 Yr. CAGR %	-14.76	33.1	33.68	7.36	9.79
Normalized Net Income, 3 Yr. CAGR %	-15.68	13.52	34.22	16.62	24.05
Diluted EPS Before Extra, 3 Yr. CAGR %	-29.5	15.98	30.19	6.85	11.35
Accounts Receivable, 3 Yr. CAGR %	3.81	11.92	5.15	-12.17	-14.49
Net Property, Plant and Equip., 3 Yr. CAGR %	156.62	141.24	37.25	-20.06	-31.33
Total Assets, 3 Yr. CAGR %	38.95	11.02	11.05	2.41	-7.77
Tangible Book Value, 3 Yr. CAGR %	48.12	5.28	1.2	-14.05	-29.09
Common Equity, 3 Yr. CAGR %	50.24	15.27	16.41	7.83	-6.23
Cash From Operations, 3 Yr. CAGR %	44.3	19.97	122.09	-45.99	41.37
Capital Expenditures, 3 Yr. CAGR %	219.67	41.5	-4.84	-47.37	-41.52
Levered Free Cash Flow, 3 Yr. CAGR %	-2.15	68.17	14.5	87.08	-14.98
Unlevered Free Cash Flow, 3 Yr. CAGR %	-0.49	67.83	13.8	83.17	-15.12
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	25.07	22.97	16.08	4.32	-5.28
Gross Profit, 5 Yr. CAGR %	28.78	30.56	17.77	0.6	-11.32
EBITDA, 5 Yr. CAGR %	1.06	-3.18	0.87	10.63	33.48
EBITA, 5 Yr. CAGR %	-3.26	-8.19	-6.01	14.8	40.02
EBIT, 5 Yr. CAGR %	-5.68	-11.41	-8.7	12.51	42.7
Earnings From Cont. Operations, 5 Yr. CAGR %	-4.43	-5.76	-7.66	12.01	35.88
Net Income, 5 Yr. CAGR %	-4.43	-5.76	-7.66	12.01	35.88
Normalized Net Income, 5 Yr. CAGR %	-5.62	-11.72	-9.16	11.41	41.74
Diluted EPS Before Extra, 5 Yr. CAGR %	-24.08	-18.55	-18.68	4.06	35.11
Accounts Receivable, 5 Yr. CAGR %	10.52	20.84	12.5	-12.7	-3.3
Net Property, Plant and Equip., 5 Yr. CAGR %	54.28	65.15	68.58	46.41	2.06
Total Assets, 5 Yr. CAGR %	23.33	20.02	26.58	4.67	0.89
Tangible Book Value, 5 Yr. CAGR %	28.14	19.27	25.29	-6.24	-16.33
Common Equity, 5 Yr. CAGR %	27.48	22.4	35.96	9.31	3.63
Cash From Operations, 5 Yr. CAGR %	8.02	-16.77	17.2	-3.18	67.85
Capital Expenditures, 5 Yr. CAGR %	72.43	47.93	54.85	10.76	-30.98
Levered Free Cash Flow, 5 Yr. CAGR %	-25.73	19.62	37.43	24.69	15.59
Unlevered Free Cash Flow, 5 Yr. CAGR %	-24.97	19.47	36.92	24.37	15.36